+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Campylobacter Infections - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Campylobacter Infections - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Nontuberculous Mycobacterial (NTM) Infections - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Nontuberculous Mycobacterial (NTM) Infections - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 101 Pages
  • Global
From
Herpes Simplex - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Herpes Simplex - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 152 Pages
  • Global
From
Helicobacter Pylori Infections - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Helicobacter Pylori Infections - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 180 Pages
  • Global
From
Parainfluenza Virus Infection Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Parainfluenza Virus Infection Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 120 Pages
  • Global
From
Clostridium Difficile Infections Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Clostridium Difficile Infections Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
H. Pylori Infection Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

H. Pylori Infection Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
SER-109 Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SER-109 Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
REBYOTA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REBYOTA Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Vancomycin Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Vancomycin Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Metronidazole Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Metronidazole Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Vancomycin-Resistant Enterococcus Faecium Infections - Epidemiology Forecast to 2032 - Product Thumbnail Image

Vancomycin-Resistant Enterococcus Faecium Infections - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Varicella Zoster (HHV-3) Infections - Epidemiology Forecast to 2032 - Product Thumbnail Image

Varicella Zoster (HHV-3) Infections - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Klebsiella Pneumoniae Infections - Epidemiology Forecast to 2032 - Product Thumbnail Image

Klebsiella Pneumoniae Infections - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Clostridium Difficile Infections - Epidemiology Forecast to 2032 - Product Thumbnail Image

Clostridium Difficile Infections - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Nontuberculous Mycobacterial (NTM) Infections - Epidemiology Forecast to 2032 - Product Thumbnail Image

Nontuberculous Mycobacterial (NTM) Infections - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Nontuberculous Mycobacteria (Ntm) Infections - Pipeline Insight, 2021 - Product Thumbnail Image

Nontuberculous Mycobacteria (Ntm) Infections - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 60 Pages
  • Global
From
Severe Acute Respiratory Syndrome Coronavirus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Severe Acute Respiratory Syndrome Coronavirus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 129 Pages
  • Global
From
BK Virus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

BK Virus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 140 Pages
  • Global
From
Arbovirus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034? - Product Thumbnail Image

Arbovirus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

  • Report
  • May 2024
  • 139 Pages
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more